1According to the CDC, for children 3-17 y.o in the US, approximately ______ or ____% have been diagnosed with depression
- 1.9 million
- 3.2%
2According to the CDC, for children 3-17 y.o in the US, approximately ______ or ____% have been diagnosed with anxiety
- 4.4 million
- 7.1%
3According to the CDC, for children 3-17 y.o in the US, approximately ______ or ____% have been diagnosed with a behavior problem
- 4.5 million
- 7.4%
4Anxiety d/o are among the most common disorders seen in children and adolescents; Rates among girls is ____ to boys until _____, then girls ___ boys
- =
- Adolescence
- >
5Schizophrenia in people under the age of 13 is rare- only _____
4 percent of 1 percent
6_____ and ______ at increased risk of having experienced __ or more types of adverse childhood experiences (ACEs)
- Women
- Racial/ethnic minority groups
- 4
7DSM-5 Criteria: For at least 2 weeks, the patient experiences 5 of the following: ______, ______, _____, ______, ______, _____, _____, _____
- Feelings of hopelessness, worthlessness, guilt
- Anhedonia
- Increased or decreased appetite
- Psychomotor agitation or slowing
- Fatigue or loss of energy
- Hypersomnia/insomnia
- Decreased concentration
- Thoughts about death or suicide with or without plan/intent
8According to the CDC in 2017, suicide was the 2nd leading cause of death among ages ___ - ____
- 10-34
9FDA approved meds for Major Depressive Disorder (MDD) include _____ for ages ____ & _____ for ages ______
- Prozac (fluoxetine) for ages 8+
- Lexapro (escitalopram) for ages 12+
10Other meds not FDA approved for Major Depressive Disorder (MDD) include ______, _____, _____, _____, and ______
- Zoloft (sertraline)
- Celexa (citalopram)
- Remeron (mirtazapine) for sleep and appetite
- Trazodone (desyrel) for sleep
- OTC Melatonin for sleep
11Side effects of SSRIs include _____, _____, _____, _____ & _____
- Insomnia
- GI
- Headache
- Agitation
- Black Box Warning…
12Major Depressive Disorder (MDD) Gold standard treatment = _______
therapy + medication
13Nonsuicidal Self-Injury (NSSI) is common in _____
- Adolescents (14-24%)
14Mania is _____ or _____ mood and ______ energy lasting >/= ______
- Euphoric or irritable
- Increased
- 1 week
15Hypomania: Same as mania, but only lasts _____and does NOT cause marked impairment in _____ or ______ functioning, necessitate hospitalization, or have ______
- 4+ days
- social or occupational
- psychotic features
16FDA approved meds for Bipolar Spectrum Disorder (BSD) include ______ for ages _____, ______ for ages _____, ______ for ages _____, & ______ for ages _____
- Olanzapine (Zyprexa) for ages 13+
- risperidone (Risperdal) for ages 10+
- quetiapine (Seroquel) for ages 10+
- aripiprazole (Abilify) for ages 10+
17Olanzapine (Zyprexa) for BSD tx dosing and use for ages _____
- 2.5mg-10mg
- Acute stabilization or maintenance
- 13+
18Risperidone (Risperdal) for BSD tx dosing and use for ages _____
- 0.5mg-6mg
- Acute mania/mixed mania
- 10+
19Quetiapine (Seroquel) for BSD tx dosing and use for ages _____
- 50mg-600mg
- Acute mania/mixed mania
- 10+
20Aripiprazole (Abilify) for BSD tx dosing and use for ages _____
- 2mg-30mg
- Acute stabilization or maintainance
- 10+
21Other meds not FDA approved for BSD include _____ & ______
- Depakote & Lithium
- (anticonvulsants/mood stabilizers)
22Monitor ______ with Depakote
- Hepatic functioning
23Monitor ______ & ______ with Lithium
- Renal & thyroid functioning
24FDA approved meds for Generallized Anxiety d/o (GAD) includes _______ for ages ______
- Duloxetine (Cymbalta) for ages 7+
25Duloxetine (Cymbalta) is an _____ used to tx GAD in ages ____. Need to monitor for _____ & ____
- SNRI
- 7+
- HR & BP changes